Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis
Open Access
- 1 October 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (10), 1813-1820
- https://doi.org/10.1038/mt.2011.92
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeuticsGene Therapy, 2010
- Systemic Therapy of Disseminated Myeloma in Passively Immunized Mice Using Measles Virus-infected Cell CarriersMolecular Therapy, 2010
- Intelligent Design: Combination Therapy With Oncolytic VirusesMolecular Therapy, 2010
- Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian CancerCancer Research, 2010
- Mesenchymal Stem Cell Carriers Protect Oncolytic Measles Viruses from Antibody Neutralization in an Orthotopic Ovarian Cancer Therapy ModelClinical Cancer Research, 2009
- Protein Kinase PKR Mediates the Apoptosis Induction and Growth Restriction Phenotypes of C Protein-Deficient Measles VirusJournal of Virology, 2009
- An Immunocompetent Murine Model for Oncolysis with an Armed and Targeted Measles VirusMolecular Therapy, 2007
- Preclinical Pharmacology and Toxicology of Intravenous MV-NIS, an Oncolytic Measles Virus Administered With or Without CyclophosphamideClinical Pharmacology & Therapeutics, 2007
- A Vectored Measles Virus Induces Hepatitis B Surface Antigen Antibodies While Protecting Macaques against Measles Virus ChallengeJournal of Virology, 2007
- Beitrag zur kollektiven Behandlung pharmakologischer ReihenversucheNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1931